Tempus ECG-Low EF vs Merlin.net

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Tempus ECG-Low EF
by Tempus
VS
Merlin.net
by Abbott (formerly St. Jude Medical)

AI Verdict

Tempus ECG-Low EF is an AI diagnostic tool focused on analyzing ECGs to detect signs of low left ventricular ejection fraction, aiding in the early identification of heart failure risk. In contrast, Merlin.net is a remote monitoring platform for managing data from patients with implanted cardiac devices, enabling ongoing follow-up and device performance tracking. While both operate in cardiology, they address different stages of patient care: diagnosis versus post-implantation management.

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if your primary goal is to screen and identify patients aged 40 or older who may be at risk for heart failure due to low left ventricular ejection fraction, using standard 12-lead ECG recordings. This tool is ideal for aiding clinicians in quickly flagging patients for further diagnostic evaluation, particularly in settings like emergency medicine or internal medicine where early detection of cardiac dysfunction is crucial.

View Tempus ECG-Low EF →

Choose Merlin.net if…

Choose Merlin.net if you need a comprehensive, web-based platform for the remote monitoring and management of patients with Abbott implanted cardiac devices. This tool is best suited for cardiologists and healthcare facilities focused on post-implantation care, enabling efficient remote follow-up, real-time device performance tracking, and streamlined patient communication to support ongoing clinical decision-making.

View Merlin.net →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Tempus ECG-Low EF Merlin.net
Deployment Integrates with current ECG platforms and electronic health records (EHRs). Web-based
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tempus ECG-Low EF

Tempus ECG-Low EF is designed for seamless integration into existing healthcare facility workflows and EHR systems, operating without a dedicated user interface and providing a simple binary output. This 'behind-the-scenes' operation minimizes the learning curve and disruption for clinicians, making it highly usable within established clinical practices.

Clinical Value

Tempus ECG-Low EF

Tempus ECG-Low EF offers significant clinical value by enabling early, AI-driven detection of low LVEF from standard 12-lead ECGs, a condition often missed and traditionally requiring more advanced imaging. This predictive capability allows for proactive identification of patients at risk for heart failure, potentially leading to timely interventions and improved patient outcomes.

Pricing & Value

Tie

Both Tempus ECG-Low EF and Abbott Merlin.net explicitly state 'contact vendor' for pricing information. Without specific pricing models or publicly available cost details, it is impossible to conduct a head-to-head comparison of their value propositions.

Enterprise Readiness

Merlin.net

Both tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, and BAA. However, Merlin.net explicitly highlights 'EHRDirectu2122 data transfer for seamless EHR integration (HL7 standards)' and provides dedicated resources for this, indicating a more robust and clearly articulated strategy for interoperability within complex healthcare IT environments.

Innovation

Tempus ECG-Low EF

Tempus ECG-Low EF's core innovation lies in its AI-powered algorithm that analyzes standard 12-lead ECGs to detect signs of low LVEF, a condition traditionally requiring more advanced and costly imaging. This represents a disruptive approach to early disease detection and risk stratification using readily available data.

Support & Docs

Merlin.net

Abbott's Merlin.net offers more explicitly detailed and readily available support and documentation, including comprehensive help manuals, integration FAQs, visual guides, and dedicated education and training resources for clinicians. While Tempus AI provides general customer support, specific documentation for ECG-Low EF was less prominent in the search results.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Tempus ECG-Low EF Merlin.net
Name Tempus ECG-Low EF Merlin.net
Company Tempus Abbott (formerly St. Jude Medical)
Description FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF ≤40%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. Web-based remote monitoring platform for clinicians to manage data from patients with implanted cardiac devices, enabling remote follow-up, device performance monitoring, and informed clinical decisions.
Mobile App 1 yes (myMerlin™ mobile application)
API Available 1 yes
Data Export 1 yes (to EHR systems, PDF reports, HL7/IEEE .xml, GDF .xml, VA Report .txt)
Categories Cardiology AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology

Videos

Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and Merlin.net.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tempus ECG-Low EF integrates into existing workflows by analyzing routine 12-lead ECGs to identify patients aged 40 and older at risk of heart failure due to low LVEF, prompting further diagnostic evaluation like an echocardiogram. Merlin.net streamlines the remote management of patients with Abbott implanted cardiac devices, such as pacemakers or ICDs, by providing clinicians with device data, alerts, and the ability to remotely adjust device settings, reducing the need for in-person visits.
Tempus ECG-Low EF integrates with existing ECG platforms and EHRs, exchanging input ECG data and metadata, and returning a binary 'Low LVEF Detected' or 'Not Detected' output directly into clinical workflows. Merlin.net utilizes EHRDirectu2122 data transfer to automatically export follow-up data, including device performance and clinical trends, to a clinic's EHR system using HL7 standards, providing an integrated view of patient data and automating administrative tasks.
Tempus ECG-Low EF demonstrated a sensitivity of 86% and a specificity of 83% for classifying patients with low LVEF (u226440%), with a negative predictive value of 98% and a positive predictive value of 38%. Physicians should interpret the binary 'Low LVEF Detected' or 'Not Detected' output as a diagnostic aid, not a standalone diagnosis, and integrate it with other clinical information to consider further diagnostic evaluation, such as an echocardiogram, for positive results.
Tempus ECG-Low EF's system, with its strict access controls and audited roles, implies logging of user interactions and the analysis of ECGs with their binary outputs. Merlin.net provides audit logging of user activity, access events, data exports, and administrative changes, and for remote programming, it generates a separate report to confirm the execution of programmed changes.
For Tempus ECG-Low EF, the learning curve is likely minimal for interpreting the binary output, with value realized quickly by identifying at-risk patients from routine ECGs for earlier intervention. Merlin.net requires familiarity with its web-based platform for managing device data and patient follow-ups, but its streamlined remote monitoring features, automated alerts, and EHR integration can offer rapid time-to-value by improving efficiency and reducing in-person visits.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Tempus ECG-Low EF or Merlin.net

Backers

Who funded each tool's parent company.

Tempus ECG-Low EF

AI Tool Finder
AI-powered search. Results may not be comprehensive.